Nuclea Biotechnologies Lands $554,850 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b8956ba-50d8-4e05-a304-970fd6a76094&Preview=1 - Date
5/3/2012 - Company Name
Nuclea Biotechnologies - Mailing Address
105 South Street Pittsfield, MA 01201 - Company Description
Nuclea Biotechnologies’ primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases. - Website
http://www.nucleabiomarkers.com - Transaction Type
Venture Equity - Transaction Amount
$554,850 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
